Hillsdale Investment Management, recently announced the acquisition of new stake in Harte Hanks Inc. (NASDAQ:HHS). This fresh investment now brings its stake to 4.67% valued currently at $3.94 million. In addition, Renaissance Technologies LLC raised its holdings by 0.13 million to 0.18 million shares. And The Vanguard Group, Inc. has lifted its position by 66.55% or 68280.0 shares – to 0.17 million shares.
With over 0.11 million Harte Hanks Inc. (HHS) shares trading Tuesday and a closing price of $12.31 on the day, the dollar volume was approximately $1.3 million. The shares have shown a negative half year performance of -7.93% and its price on 01/24/23 lost nearly -10.34%. Currently, there are 7.12M common shares owned by the public and among those 5.22M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 1 analysts who have offered their price forecasts for HHS have a consensus price objective of $22.00. The analysts have set the share’s price value over the next 12 months at a high of $22.00 and a low of $22.00. The average price target is 44.05% above its recent price level and an upside to the estimated low will see the stock gain 44.05% over that period. But an upside of 44.05% will see the stock hit the forecast high price target while median target price for the stock is $22.00.
Insiders at the company have transacted a total of 31 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 19 of these insider trades were purchases, accounting for 161,379 shares. Insider sales of the common stock occurred on 12 occasions, with total insider shares sold totaling 189,011 shares.
The top 3 mutual fund holders in Harte Hanks Inc. are Vanguard Total Stock Market Index, Warburg Value Fund, and CS Invt. Fds. 2 -. Vanguard Total Stock Market Index owns 0.15 million shares of the company’s stock, all valued at over $1.8 million. CS Invt. Fds. 2 – now owns shares totaling to 1.63% of the shares outstanding.
Shares of Harte Hanks Inc. (NASDAQ: HHS) opened at $13.70, down -$0.03 from a prior closing price of $13.73. However, the script later moved the day high at 13.70, down -10.34%. The company’s stock has a 5-day price change of -9.75% and 15.48% over the past three months. HHS shares are trading 5.30% year to date (YTD), with the 12-month market performance up to 67.94% higher. It has a 12-month low price of $6.34 and touched a high of $17.88 over the same period. HHS has an average intraday trading volume of 53.72K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.42%, 6.64%, and 9.52% respectively.
Institutional ownership of Harte Hanks Inc. (NASDAQ: HHS) shares accounts for 46.00% of the company’s 7.12M shares outstanding. Mutual fund holders own 38.88%, while other institutional holders and individual stakeholders account for 8.94% and 25.50% respectively.
It has a market capitalization of $82.85M and a beta (3y monthly) value of 0.85. The stock’s trailing 12-month PE ratio is 6.42, while the earnings-per-share (ttm) stands at $1.92. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.20% over the week and 5.47% over the month.
Analysts forecast that Harte Hanks Inc. (HHS) will achieve an EPS of $0.4 for the current quarter, $0.39 for the next quarter and $1.71 for 2023. The lowest estimate earnings-per-share for the quarter is $0.39 while analysts give the company a high EPS estimate of $0.42. Comparatively, EPS for the current quarter was $0.52 a year ago. Earnings per share for the fiscal year are expected to increase by 617.00%, and -5.68% over the next financial year.
Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”